Genetic Variants Increasing TAS2R38 Bitter Taste Receptor Sensitivity Are Associated With Lower Postprandial Glycemia
Diabetes · 01.12.2025 · 74 (12) · 2444-2454
DOI: 10.2337/db25-0614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 20.11.2025. Verfasst von Julie E Gervis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Blood Glucose, Postprandial Period, Taste. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Division of Diabetes, Endocrinology, and Metabolic Diseases, Novo Nordisk Fonden.
Abstract (Originalsprache)
TAS2R38 is a bitter taste receptor that influences bitter taste perception and diet and is also found in intestinal L cells that store and secrete glucagon-like peptide 1 (GLP-1). Preclinical studies have linked TAS2R38 activation to postprandial GLP-1 secretion, fueling interest in TAS2R38 as a therapeutic target for glucose regulation; however, evidence in humans remains limited. To further establish TAS2R38 actions in glucose homeostasis, we analyzed data from ∼220,000 European adults without type 2 diabetes in the UK Biobank to test whether functional variants conferring TAS2R38 sensitivity were associated with blood glucose. We found that individuals with two copies of a haplotype increasing receptor sensitivity (PAV) had significantly lower 0–2-h (i.e., postprandial) glucose than those with two copies of a nonfunctional haplotype (AVI), following a dose–response relationship per PAV haplotype. These associations were replicated in published genome-wide association studies of 2-h glucose, persisted after adjustment for diet and lifestyle behaviors related to bitter taste perception, and were not seen for variants in other bitter taste receptors without putative roles in glucose metabolism (TAS2R14 and TAS2R19). Collectively, these findings provide evidence in humans consistent with direct TAS2R38 actions in postprandial glycemia, supporting TAS2R38 as a novel therapeutic target for glucose regulation. Article Highlights The TAS2R38 bitter taste receptor, recently identified within intestinal L cells, has been shown to modulate GLP-1 secretion in preclinical models; however, evidence in humans remains limited. We harnessed functional variants comprising three canonical diplotypes of TAS2R38 to study the role of TAS2R38 in glucose homeostasis in humans. In a large sample of adults without type 2 diabetes, we found that individuals with more sensitive TAS2R38 receptors had lower postprandial glucose levels, independent of diet and lifestyle habits. Our findings provide evidence in humans supporting direct TAS2R38 actions in postprandial glycemia and highlight TAS2R38 as a potential therapeutic target for impaired glucose regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.
- Department of Medicine, Harvard Medical School, Boston, MA.
- Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.
- Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA.
- Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO.
- Diabetes Unit, Endocrine Division, Department of Medicine, Massachusetts General Hospital, Boston, MA.
ORCID-Profile: Julie E Gervis, Kenneth E Westerman, Jordi Merino, Sara J Cromer, Miriam S Udler
Förderung
- NIDDK NIH HHS
- Division of Diabetes, Endocrinology, and Metabolic Diseases
- Novo Nordisk Fonden
- European Foundation for the Study of Diabetes
- European Union Studies Association
- American Diabetes Association
Zitieren
APA
Gervis, J. E., Westerman, K. E., Cole, J. B., Merino, J., Cromer, S. J., & Udler, M. S. (2025). Genetic Variants Increasing TAS2R38 Bitter Taste Receptor Sensitivity Are Associated With Lower Postprandial Glycemia. Diabetes, 74(12), 2444-2454. https://doi.org/10.2337/db25-0614
Vancouver
Gervis JE, Westerman KE, Cole JB, Merino J, Cromer SJ, Udler MS. Genetic Variants Increasing TAS2R38 Bitter Taste Receptor Sensitivity Are Associated With Lower Postprandial Glycemia. Diabetes. 2025;74(12):2444-2454. doi:10.2337/db25-0614
BibTeX
@article{Gervis2025,
author = {Gervis, Julie E and Westerman, Kenneth E and Cole, Joanne B and Merino, Jordi and Cromer, Sara J and Udler, Miriam S},
title = {Genetic Variants Increasing TAS2R38 Bitter Taste Receptor Sensitivity Are Associated With Lower Postprandial Glycemia},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {12},
pages = {2444--2454},
doi = {10.2337/db25-0614}
}
EUVIMED